Clinical Trials Sponsored by Imbio

Total 6 results

Seoul National University Hospital
Pharos iBio Co., Ltd.

Recruiting

Chk2 Inhibitor for Recurrent EpitheliAl periToneal, fallopIan or oVarian cancEr (CREATIVE Phase IA Trial) (CREATIVE)

Platinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-refractory Ovarian Carcinoma

Korea, Republic of
Seoul National University Hospital
Pharos iBio Co., Ltd.

Recruiting

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PHI 101 for the Treatment of AML

Relapsed or Refractory Acute Myeloid Leukemia

Korea, Republic of
Imbio
National Cancer Institute (NCI); Mayo Clinic; University of Michigan; University... and other collaborators

Completed

Personalized Smoking Cessation Tool Based on Patient Lung CT Image

Smoking Cessation

United States
State-Financed Health Facility "Samara Regional...
INBIO, LLC

Recruiting

Safety and Efficacy of the Transfusion of UCB in Patients With an ASD Depending on the Degree of HLA Compatibility. (ASD-HLA2019)

Autism Spectrum Disorder | Autism

Russian Federation
State-Financed Health Facility "Samara Regional...
INBIO, LLC

Recruiting

Estimation of the Safety and Efficiency Transfusion of HLA Matched CBU in Patients With CP (CP-HLA2019)

Cerebral Palsy

Russian Federation
Central Institute of Mental Health, Mannheim
German Federal Ministry of Education and Research; Heidelberg University -... and other collaborators

Completed

Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder (ON-ICE)

Alcoholism | Alcohol Use Disorder | Alcohol Addiction

Germany

Clinical Trials Sponsored by Imbio

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations